Income Statement GenIP plc

Stocks

Market Closed - London S.E. 11:35:03 2026-08-14 EDT			5-day change	1st Jan Change
3.600 ^GBX	0.00%		-7.69%	-58.38%

08-11	Redcentric buyback progamme; Synectics product launch	AN
08-11	GenIP Bags Orders for AI-driven Products from Universities	MT

10a6c83.hvZVsJUvcomOCCxeL47cr2mi_JFOYsdxk9pnXHcO9eU.x9t4-fdZItHYZl09G_uu8DiaiscgT4s4-J8xDTI2trSxvHjx5Esf0L9KQw

Published financial data: GENIP PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2024
Revenues	148K
Total Revenues	148K
Cost of Goods Sold, Total	129K
Gross Profit	18.19K
Selling General & Admin Expenses, Total	949K
Amortization of Goodwill and Intangible Assets - (IS)	65.02K
Other Operating Expenses, Total	1.01M
Operating Income	-996K
Interest Expense, Total	-116
Interest And Investment Income	2.18K
Net Interest Expenses	2.06K
Currency Exchange Gains (Loss)	-70.39K
EBT, Excl. Unusual Items	-1.06M
EBT, Incl. Unusual Items	-1.06M
Earnings From Continuing Operations	-1.06M
Net Income to Company	-1.06M
Net Income - (IS)	-1.06M
Net Income to Common Incl Extra Items	-1.06M
Net Income to Common Excl. Extra Items	-1.06M
Per Share Items
Net EPS - Basic	-0.06
Basic EPS - Continuing Operations	-0.06
Basic Weighted Average Shares Outstanding	17.52M
Net EPS - Diluted	-0.06
Diluted EPS - Continuing Operations	-0.06
Diluted Weighted Average Shares Outstanding	17.52M
Normalized Basic EPS	-0.04
Normalized Diluted EPS	-0.04
Supplemental Items
EBITDA	-931K
EBITA	-931K
EBIT	-996K
Normalized Net Income	-665K
Supplemental Operating Expense Items
Marketing Expenses	52K
Selling and Marketing Expenses	62.4K
General and Administrative Expenses	848K
Stock-Based Comp., G&A Exp. (Total)	431K
Total Stock-Based Compensation	431K

Fiscal Period: December	2024
Assets
Cash And Equivalents	972K
Total Cash And Short Term Investments	972K
Accounts Receivable, Total	3.67K
Other Receivables	317K
Total Receivables	321K
Prepaid Expenses	83.49K
Total Current Assets	1.38M
Other Intangibles, Total	255K
Total Assets	1.63M
Liabilities
Accounts Payable, Total	25.41K
Accrued Expenses, Total	122K
Short-term Borrowings	134K
Unearned Revenue Current, Total	78.39K
Total Current Liabilities	360K
Total Liabilities	360K
Common Stock, Total	102K
Additional Paid In Capital	1.72M
Retained Earnings	-887K
Comprehensive Income and Other	335K
Total Common Equity	1.27M
Total Equity	1.27M
Total Liabilities And Equity	1.63M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	17.52M
ECS Total Common Shares Outstanding	17.52M
Book Value / Share	0.07
Tangible Book Value	1.02M
Tangible Book Value Per Share	0.06
Total Debt	134K
Net Debt	-839K
Account Code - Inventory Valuation	3
Full Time Employees	1
Accumulated Allowance for Doubtful Accounts (Supple)	19.89K

Fiscal Period: December	2024
Net Income	-1.06M
Amortization of Goodwill and Intangible Assets - (CF)	65.02K
Depreciation & Amortization, Total	65.02K
Stock-Based Compensation (CF)	431K
Other Operating Activities, Total	-2.18K
Change In Accounts Receivable	-309K
Change In Accounts Payable	177K
Change in Unearned Revenues	34.02K
Cash from Operations	-668K
Sale (Purchase) of Intangible assets	-152K
Other Investing Activities, Total	2.18K
Cash from Investing	-149K
Short Term Debt Issued, Total	134K
Total Debt Issued	160K
Issuance of Common Stock	2.83M
Other Financing Activities, Total	-1.01M
Cash from Financing	1.98M
Net Change in Cash	1.17M
Supplemental Items
Cash Interest Paid	116
Net Debt Issued / Repaid	160K

Fiscal Period: December	2024
Margin Analysis
Gross Profit Margin %	12.32
SG&A Margin	642.9
EBITDA Margin %	-630.58
EBITA Margin %	-630.58
EBIT Margin %	-674.62
Income From Continuing Operations Margin %	-720.91
Net Income Margin %	-720.91
Net Avail. For Common Margin %	-720.91
Normalized Net Income Margin	-450.57
Short Term Liquidity
Current Ratio	3.83
Quick Ratio	3.59
Operating Cash Flow to Current Liabilities	-1.86
Long Term Solvency
Total Debt/Equity	10.5
Total Debt / Total Capital	9.5
Total Liabilities / Total Assets	22.04
EBIT / Interest Expense	-8.59K
EBITDA / Interest Expense	-8.02K
(EBITDA - Capex) / Interest Expense	-8.02K
Total Debt / EBITDA	-0.14
Net Debt / EBITDA	0.9
Total Debt / (EBITDA - Capex)	-0.14
Net Debt / (EBITDA - Capex)	0.9